Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sophie Fougeray"'
Autor:
Pauline Thomas, Natacha Galopin, Emma Bonérandi, Béatrice Clémenceau, Sophie Fougeray, Stéphane Birklé
Publikováno v:
Cancers, Vol 13, Iss 21, p 5445 (2021)
Malignant central nervous system tumors are the leading cause of cancer death in children. Progress in high-throughput molecular techniques has increased the molecular understanding of these tumors, but the outcomes are still poor. Even when efficaci
Externí odkaz:
https://doaj.org/article/ae313db6a6094e169834075363a59a1f
Autor:
Julien Fleurence, Sophie Fougeray, Meriem Bahri, Denis Cochonneau, Béatrice Clémenceau, François Paris, Andras Heczey, Stéphane Birklé
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
Target selection is a key feature in cancer immunotherapy, a promising field in cancer research. In this respect, gangliosides, a broad family of structurally related glycolipids, were suggested as potential targets for cancer immunotherapy based on
Externí odkaz:
https://doaj.org/article/e397588521e445a98b10cf7afd44ba5c
Autor:
Jeannig Berrou, Sophie Fougeray, Marion Venot, Victor Chardiny, Jean-François Gautier, Nicolas Dulphy, Antoine Toubert, Marie-Noëlle Peraldi
Publikováno v:
PLoS ONE, Vol 9, Iss 1 (2014)
Externí odkaz:
https://doaj.org/article/6b597472db46446c9299f31cddc66c10
Autor:
Jeannig Berrou, Sophie Fougeray, Marion Venot, Victor Chardiny, Jean-François Gautier, Nicolas Dulphy, Antoine Toubert, Marie-Noëlle Peraldi
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e62418 (2013)
Patients with Type 2 diabetes (T2D) are highly susceptible to infection and have an increased incidence of some tumors, possibly due to immune system dysfunction. In the innate cellular immune system, Natural Killer (NK) lymphocytes are important eff
Externí odkaz:
https://doaj.org/article/baa4daf4a218477783eaf90c155eb1a9
Autor:
Béatrice Clémenceau, Stéphane Birklé, Natacha Galopin, Pauline Thomas, Sophie Fougeray, Emma Bonérandi
Publikováno v:
Cancers, Vol 13, Iss 5445, p 5445 (2021)
Cancers
Cancers, 2021, 13 (21), pp.5445. ⟨10.3390/cancers13215445⟩
Cancers
Cancers, 2021, 13 (21), pp.5445. ⟨10.3390/cancers13215445⟩
Simple Summary T cells that are genetically engineered to express chimeric antigen receptors constitute an effective new therapy with curative potential for patients with hematological tumors. The value of chimeric antigen receptor T cells in childho
Autor:
Claire Pecqueur, Sébastien Faraj, Lisa Oliver, Julien Fleurence, Pierre Marquet, Meriem Bahri, Stéphane Birklé, Marion Rabé, Fanny Geraldo, François Paris, François M. Vallette, Sophie Fougeray, Joëlle Veziers, Catherine Gratas, Emilie Pinault, Sarah Vermeulen
Publikováno v:
International Journal of Cancer. 146:424-438
Stem cell chemo-resistance is still challenging the efficacy of the front-line temozolomide against glioblastoma. Novel therapies are urgently needed to fight those cells in order to control tumor relapse. Here, we report that anti-O-acetyl-GD2 adjuv
Autor:
Claudia Rossig, Meriem Bahri, Sarah Vermeulen, François Paris, Sareetha Kailayangiri, Stéphane Birklé, Sophie Fougeray, Natacha Galopin
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, 2021, Online ahead of print. ⟨10.1007/s00262-021-02968-7⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2021, Online ahead of print. ⟨10.1007/s00262-021-02968-7⟩
Cancer Immunology, Immunotherapy, 2021, Online ahead of print. ⟨10.1007/s00262-021-02968-7⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2021, Online ahead of print. ⟨10.1007/s00262-021-02968-7⟩
International audience; Immunotherapy with anti-GD2 monoclonal antibodies (mAbs) provides some benefits for patients with neuroblastoma (NB). However, the therapeutic efficacy remains limited, and treatment is associated with significant neuropathic
Autor:
Béatrice Clémenceau, Julien Fleurence, Sophie Fougeray, Denis Cochonneau, François Paris, Stéphane Birklé, Andras Heczey, Meriem Bahri
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
Target selection is a key feature in cancer immunotherapy, a promising field in cancer research. In this respect, gangliosides, a broad family of structurally related glycolipids, were suggested as potential targets for cancer immunotherapy based on
Autor:
Stéphane Birklé, Meriem Bahri, Sophie Fougeray, Sébastien Faraj, Julien Fleurence, Mohamed Ben Mostefa Daho
Publikováno v:
Journal of visualized experiments : JoVE
Journal of visualized experiments : JoVE, 2018, e58291, epub ahead of print. ⟨10.3791/58291⟩
Journal of visualized experiments : JoVE, JoVE, 2018, e58291, epub ahead of print. ⟨10.3791/58291⟩
Journal of visualized experiments : JoVE, 2018, e58291, epub ahead of print. ⟨10.3791/58291⟩
Journal of visualized experiments : JoVE, JoVE, 2018, e58291, epub ahead of print. ⟨10.3791/58291⟩
International audience; Potentiation of hostile monoclonal antibodies (mAb) by chemotherapeutic agents constitutes a valuable strategy for designing effective and safer therapy against cancer. Here we provide a protocol to identify a rational combina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::010d00e9fb1dbffd5f945d99af9db03d
https://www.hal.inserm.fr/inserm-01958827/document
https://www.hal.inserm.fr/inserm-01958827/document
Autor:
Mickaël Terme, Sébastien Faraj, Marc-David Leclair, Sophie Fougeray, Julien Fleurence, Denis Cochonneau, Stéphane Birklé, Estelle Thébaud, François Paris, Meriem Bahri
Publikováno v:
Journal of Cancer Research and Therapeutics
Journal of Cancer Research and Therapeutics, 2016, 4 (3), pp.21-30. ⟨10.14312/2052-4994.2016-5⟩
Journal of Cancer Research & Therapy, Vol 4, Iss 3, Pp 21-30 (2016)
Journal of Cancer Research and Therapeutics, Medknow Publications, 2016, 4 (3), pp.21-30. ⟨10.14312/2052-4994.2016-5⟩
Journal of Cancer Research and Therapeutics, 2016, 4 (3), pp.21-30. ⟨10.14312/2052-4994.2016-5⟩
Journal of Cancer Research & Therapy, Vol 4, Iss 3, Pp 21-30 (2016)
Journal of Cancer Research and Therapeutics, Medknow Publications, 2016, 4 (3), pp.21-30. ⟨10.14312/2052-4994.2016-5⟩
International audience; Sialic acid O-acetylation is a developmentally regulated modification of gangliosides implicated in ontogeny and tumor progression. Their existence has been underestimated in the past because of their alkali-labile nature and